Stem Cell Proteomics
Stem cells receive widespread attention in scientific literature and in society as a whole. This is inspired by their distinctive features - the ability to regenerate themselves and separate multiple lines. Embryonic stem cells (hESCs) have the ability to make all the cells in the adult body once they have received the right signals. The ability to control and regulate in vitro segregation may provide opportunities to improve the treatment of diseases that cannot be cured today, especially in the area of rehab, where the goal is to replace damaged tissue. However, there are still many challenges before hESCs can be used safely in clinical applications. In addition, social and ethical issues need to be addressed before basic science in the area can be successfully translated into clinical practice.
Related Conference of Stem Cell Proteomics
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
Stem Cell Proteomics Conference Speakers
Recommended Sessions
- Biomarkers
- Cancer Epigenetics
- Cardiovascular Proteomics
- Clinical Genomics & Clinical Proteomics
- Computational Biology, Bioinformatics, and Biostatistics
- Computing in Biomedicine and Genomics
- E-Health, Telemedicine
- Genome Projects and Genome Sequencing
- Immunogenetics and Immunology
- Metabolomics and Metabonomics
- Metabolomics in Precision Medicine
- Modern Genetics
- Pharmacogenomics
- Protein Interactions in Biology
- Proteomics and Genomics
- Proteomics and its Medicinal Research
- Proteomics Technologies
- Signaling/Computational Biomedical Data Engineering
- Stem Cell Proteomics
- Toxicogenomics and Pharmacoproteomics
- Transcriptomics
Related Journals
Are you interested in
- 3D Bioprinting, Organ Fabrication & Bioartificial Tissues - Stem Cell 2026 (Netherlands)
- Aging Biology, Longevity Science & Cellular Rejuvenation - Stem Cell 2026 (Netherlands)
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Bioinformatics, AI Models & Predictive Regeneration - Stem Cell 2026 (Netherlands)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer Stem Cells & Targeted Therapeutics - Stem Cell 2026 (Netherlands)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiac, Vascular & Musculoskeletal Regeneration - Stem Cell 2026 (Netherlands)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Clinical Translation of Stem Cell Therapies - Stem Cell 2026 (Netherlands)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- Commercialization, Biobanking & Industry Innovations - Stem Cell 2026 (Netherlands)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Ethical, Regulatory & Quality Control Frameworks - Stem Cell 2026 (Netherlands)
- Exosomes, Extracellular Vesicles & Cell-Free Therapeutics - Stem Cell 2026 (Netherlands)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Gene Editing, CRISPR Therapies & Regenerative Genomics - Stem Cell 2026 (Netherlands)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Regeneration in Neurodegenerative & Spinal Cord Disorders - Stem Cell 2026 (Netherlands)
- Regenerative Approaches in Diabetes & Metabolic Disorders - Stem Cell 2026 (Netherlands)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Immunology & Immune Modulation - Stem Cell 2026 (Netherlands)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cell Engineering & Cellular Reprogramming - Stem Cell 2026 (Netherlands)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)
- Tissue Engineering, Biomaterials & Smart Scaffolds - Stem Cell 2026 (Netherlands)